Endotherapy Devices: A 2026 Guide to Biliary Stents and Hemostasis Clips
Clinical Bottom Line Product Category Clinical Indication Key 2026 Innovations Hemostasis Clips Mechanical closure of bleeding vessels, mucosal defects, or […]
Clinical Bottom Line Product Category Clinical Indication Key 2026 Innovations Hemostasis Clips Mechanical closure of bleeding vessels, mucosal defects, or […]
Clinical Bottom Line GERD Phenotype Pathological Features Primary Management NERD (Non-Erosive Reflux Disease) Classic GERD symptoms but strict endoscopic absence
Clinical Bottom Line Feature Sump Syndrome Clinical Overview Pathophysiology A blind “sump” (pouch) formed in the distal common bile duct
Clinical Bottom Line Biologic Agent Mechanism of Action Current FDA Status (2025/2026) Dupilumab Dual blockade of IL-4 and IL-13 receptor
Clinical Bottom Line Anatomical Landmark Vascular Characteristics Clinical Vulnerability Sudeck’s Point Terminal branch of the Inferior Mesenteric Artery (IMA). High
Clinical Bottom Line Anatomical Feature Clinical Application Definition A continuous arterial arcade running along the inner mesenteric border of the
Clinical Bottom Line Feature Diagnostic & Therapeutic Standard Pathophysiology Vascular ectasia in the gastric antrum; highly associated with systemic sclerosis
Clinical Bottom Line EREFS Component Endoscopic Finding Scoring Criteria E (Exudates) White plaques / spots 0 = Absent; 1 =
Clinical Bottom Line Histological Metric Diagnostic / Therapeutic Threshold Peak Eosinophil Count (PEC) ≥15 eos/hpf (Diagnostic for EoE) Histological Remission
Clinical Bottom Line Criteria / Management 2025/2026 Guideline Consensus (ACG / AGA) Diagnostic Threshold ≥15 eosinophils per high-power field (eos/hpf)